Still A Long Way to Go: A Case for Stem Cell Technology

Published 01 Jan 2003
Reference 5170
Industry Biotechnology
Region Global
Summary

There are few industries in which the effects of technological innovation be seen as clearly as they can in the healthcare industry. Developments in devices, services and networks are in turn creating even more opportunities and innovation. This case looks specifically at developments in Stem Cell-related technologies, and the impact these might have on the treatment of certain diseases. With a particular focus on the treatment of diabetes, the case looks at the market potential of such innovations and the challenges the industry might expect to encounter going forward.

Teaching objectives

The case aims to provide a succinct overview of current developments in this rapidly developing industry sector. Including a historical industry perspective, comment on potential product development and current industry forecasts, the case raises many questions for students to consider and resolve.

Keywords
  • Stem cell
  • Cloning
  • Diabetes
  • Technology
  • Health care
  • Insurance
  • Innovation
  • Biomedical
    AR0304
  • AR2003
  • RD1103